Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a Head-Worn device calm vestibular migraine symptoms?

NCT ID NCT06540235

Symptom relief Sponsor: Otolith Labs Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a wearable device that delivers gentle vibrations through the skull can improve balance and reduce motion sickness in people with vestibular migraine. Fifty-one participants wore the device while sitting in a rotating chair and answered questions about their symptoms. Researchers compared results when the device was on versus off to see if it made a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Otolith Labs device (wearable device providing bone-conducted stimulation)
What this could lead to
If it works, this could point toward a non-drug way to ease dizziness and motion sickness in vestibular migraine.
What could go wrong
This is a small, early-stage study (51 people) testing only short-term effects in a lab. It does not prove long-term benefit or real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

51 people

The number who actually took part.

Started

Aug 2024

Finished

Dec 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Definite or probable vestibular migraine * Residing in the United States Exclusion Criteria: * Head injury (e.g. skull fracture, concussion) within the last six months * Neurodegenerative disorder * Recent use of specified medications * History of: * Vestibular neuritis / labyrinthitis * Vestibular schwannoma or acoustic neuroma * Radiographically unexplored unilateral or sudden sensorineural hearing loss * History of surgery to the skull base or head, * Surgery to the middle ear in the past 6 months, * Surgery to the inner ear (e.g. labyrinthectomy) at any time. * Eye surgery within the previous 3 months * Significant reported history of ear disease, intravenous ototoxic medications

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Vestibular migraine are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

migraine with brainstem aura

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Vestibular migraine

Contacts and locations

Locations

  • Dizzy and Vertigo Institute of Los Angeles

    Beverly Hills, California, 90211, United States

  • Medical University of South Carolina

    Charleston, South Carolina, 29425, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.